DK1829972T3 - DNA-Sekvenser med anti-repressoraktivitet - Google Patents

DNA-Sekvenser med anti-repressoraktivitet

Info

Publication number
DK1829972T3
DK1829972T3 DK06124482.8T DK06124482T DK1829972T3 DK 1829972 T3 DK1829972 T3 DK 1829972T3 DK 06124482 T DK06124482 T DK 06124482T DK 1829972 T3 DK1829972 T3 DK 1829972T3
Authority
DK
Denmark
Prior art keywords
dna sequences
regulatory sequences
repressor activity
provides
screenings
Prior art date
Application number
DK06124482.8T
Other languages
English (en)
Inventor
Arie Pieter Otte
Arhur Leo Kruckeberg
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01202581A external-priority patent/EP1273666A1/en
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Application granted granted Critical
Publication of DK1829972T3 publication Critical patent/DK1829972T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK06124482.8T 2001-07-04 2002-06-14 DNA-Sekvenser med anti-repressoraktivitet DK1829972T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01202581A EP1273666A1 (en) 2001-07-04 2001-07-04 Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US30319901P 2001-07-05 2001-07-05
EP05076209A EP1600510B1 (en) 2001-07-04 2002-06-14 DNA sequences having anti-repressor activity
US10/190,312 US7192741B2 (en) 2001-07-04 2002-07-05 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences

Publications (1)

Publication Number Publication Date
DK1829972T3 true DK1829972T3 (da) 2010-09-13

Family

ID=47915807

Family Applications (8)

Application Number Title Priority Date Filing Date
DK06124482.8T DK1829972T3 (da) 2001-07-04 2002-06-14 DNA-Sekvenser med anti-repressoraktivitet
DK02741531T DK1404872T3 (da) 2001-07-04 2002-06-14 Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet
DK06124475.2T DK1829971T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124470.3T DK1806407T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124481.0T DK1845162T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124491.9T DK1842919T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK06124465.3T DK1808488T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK05076209T DK1600510T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet

Family Applications After (7)

Application Number Title Priority Date Filing Date
DK02741531T DK1404872T3 (da) 2001-07-04 2002-06-14 Fremgangsmåde til selektion af en DNA-sekvens med transkriptionsmodulerende aktivitet med en vektor indeholdende et element med en gentranskriptionsundertrykkende aktivitet
DK06124475.2T DK1829971T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124470.3T DK1806407T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124481.0T DK1845162T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK06124491.9T DK1842919T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet
DK06124465.3T DK1808488T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med anti-repressoraktivitet
DK05076209T DK1600510T3 (da) 2001-07-04 2002-06-14 DNA-sekvenser med antirepressoraktivitet

Country Status (22)

Country Link
US (9) US7192741B2 (da)
EP (8) EP1600510B1 (da)
JP (3) JP4500044B2 (da)
KR (2) KR100942116B1 (da)
CN (1) CN1266282C (da)
AT (8) ATE466941T1 (da)
AU (3) AU2002314629B2 (da)
BR (1) BRPI0210771B8 (da)
CA (2) CA2812799C (da)
CY (1) CY1107678T1 (da)
DE (8) DE60219221T2 (da)
DK (8) DK1829972T3 (da)
ES (8) ES2344074T3 (da)
HK (1) HK1068652A1 (da)
IL (4) IL159674A0 (da)
MX (1) MXPA03011801A (da)
NO (1) NO338477B1 (da)
NZ (1) NZ530218A (da)
PT (1) PT1600510E (da)
SG (1) SG143066A1 (da)
WO (1) WO2003004704A2 (da)
ZA (1) ZA200309599B (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0210771B8 (pt) 2001-07-04 2021-05-25 Chromagenics Bv construção de dna recombinante, método para a produção de um produto de gene em uma célula, e, uso de uma sequência de dna
DK1513937T3 (da) * 2002-06-14 2011-05-16 Chromagenics Bv Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved
WO2003106674A2 (en) * 2002-06-14 2003-12-24 Chromagenics B.V. Means and methods for regulating gene expression
CA2872136C (en) 2002-07-18 2017-06-20 Merus B.V. Recombinant production of mixtures of antibodies
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
DK1573058T3 (da) 2002-12-18 2012-01-16 Chromagenics Bv Fremgangsmåde til forbedring af proteinproduktion
AU2003290453A1 (en) 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
CA2527694C (en) 2003-05-30 2015-07-14 Hendricus Renerus Jacobus Mattheus Hoogenboom Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
CN1863918B (zh) 2003-10-02 2011-03-30 克鲁塞尔荷兰公司 用于重组腺病毒的包装细胞
WO2005059149A2 (en) * 2003-12-12 2005-06-30 Chromagenics B.V. Improved protein production
EP1737971B1 (en) 2004-01-20 2017-08-16 Merus N.V. Mixtures of binding proteins
KR101188013B1 (ko) 2004-07-08 2012-10-08 크로마제닉스 비.브이. 핵산 발현의 개선을 위한 신규한 서열
WO2006018319A1 (en) * 2004-08-18 2006-02-23 Bayer Cropscience Gmbh Plants with increased plastidic activity of r3 starch-phosphorylating enzyme
ES2384391T3 (es) * 2004-11-08 2012-07-04 Chromagenics B.V. Selección de células hospedantes que expresan proteína a altos niveles
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
BRPI0517380A (pt) * 2004-11-08 2008-10-07 Chromagenics Bv molécula de dna, cassete de expressão, célula hospedeira, e, métodos para gerar uma célula hospedeira que expressa um polipeptìdeo de interesse e para produzir um polipeptìdeo de interesse
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
EP1870470B1 (en) * 2004-11-18 2011-04-06 National University of Corporation Hiroshima University Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant
EP1996705B1 (en) 2006-03-20 2011-08-31 ChromaGenics B.V. Expression augmenting dna fragments, use thereof, and methods for finding thereof
US20080124760A1 (en) 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
CN101627123A (zh) * 2007-01-08 2010-01-13 米利波尔公司 消除基因扩增的高表达细胞系
BRPI1013141A2 (pt) 2009-06-15 2015-10-06 Cellagenics B V novos marcadores selecionaveis rigorosos
US8566596B2 (en) 2010-08-24 2013-10-22 Cisco Technology, Inc. Pre-association mechanism to provide detailed description of wireless services
DK2611915T3 (da) 2010-09-01 2015-06-22 Cellagenics B V Nukleinsyrefragmenter fra en ribosomal proteinpromoter til forstærkning af genekspression
ES2743399T3 (es) 2012-04-20 2020-02-19 Merus Nv Métodos y medios para la producción de moléculas heterodiméricas similares a Ig
CN104736174B (zh) 2012-07-06 2019-06-14 根马布私人有限公司 具有三重突变的二聚体蛋白质
EP3470431A1 (en) 2012-09-27 2019-04-17 Merus N.V. Bispecific igg antibodies as t cell engagers
US10417380B1 (en) 2013-12-31 2019-09-17 Mckesson Corporation Systems and methods for determining and communicating a prescription benefit coverage denial to a prescriber
US10489552B2 (en) 2014-02-14 2019-11-26 Mckesson Corporation Systems and methods for determining and communicating patient incentive information to a prescriber
US11279770B2 (en) 2014-02-28 2022-03-22 Merus N.V. Antibody that binds ErbB-2 and ErbB-3
WO2015130172A1 (en) 2014-02-28 2015-09-03 Merus B.V. Antibodies that bind egfr and erbb3
US10157262B1 (en) 2015-03-10 2018-12-18 Mckesson Corporation Systems and methods for determining patient financial responsibility for multiple prescription products
DK3115376T3 (da) 2015-07-10 2018-11-26 Merus Nv Humant cd3-bindende antistof
CN108602888B (zh) 2015-10-23 2022-10-04 美勒斯公司 抑制癌症生长的结合分子
US11514137B1 (en) 2016-03-30 2022-11-29 Mckesson Corporation Alternative therapy identification system
US10999224B1 (en) 2017-02-01 2021-05-04 Mckesson Corporation Method and apparatus for parsing an electronic message and constructing multiple differently prioritized messages therefrom
AU2018246873B2 (en) 2017-03-31 2021-05-06 Merus N.V. ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment f cells that have an NRG1 fusion gene
SG11202001050PA (en) 2017-08-09 2020-03-30 Merus Nv Antibodies that bind egfr and cmet
US10862832B1 (en) 2018-07-24 2020-12-08 Mckesson Corporation Computing system and method for automatically reversing an action indicated by an electronic message
US11043437B2 (en) 2019-01-07 2021-06-22 Applied Materials, Inc. Transparent substrate with light blocking edge exclusion zone
US11562437B1 (en) 2019-06-26 2023-01-24 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
US11636548B1 (en) 2019-06-26 2023-04-25 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
EP3772518A1 (en) 2019-08-07 2021-02-10 Merus N.V. Modified human variable domains
WO2021155369A1 (en) * 2020-01-31 2021-08-05 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods to identify genetic silencers and applications thereof
US11610240B1 (en) 2020-02-17 2023-03-21 Mckesson Corporation Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction
IL298394A (en) 2020-05-21 2023-01-01 Merus Nv Methods and means for producing ig-like molecules
US11587657B2 (en) 2020-09-04 2023-02-21 Mckesson Corporation Method, apparatus, and computer program product for performing an alternative evaluation procedure in response to an electronic message
CN113539357B (zh) * 2021-06-10 2024-04-30 阿里巴巴达摩院(杭州)科技有限公司 基因检测方法、模型训练方法、装置、设备及系统

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US719271A (en) * 1902-01-13 1903-01-27 Solomon P Smith Furnace.
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5972605A (en) 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
CN1184506A (zh) * 1995-03-24 1998-06-10 盐野义制药株式会社 基因表达抑制相关性dna分子和新的蛋白质
DE19539493A1 (de) * 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6037525A (en) * 1996-08-01 2000-03-14 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
WO2000005393A2 (en) 1998-07-21 2000-02-03 Cobra Therapeutics Limited A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
WO2000009749A1 (en) * 1998-08-14 2000-02-24 Stichting Voor De Technische Wetenschappen Method of detecting a dna sequence, a dna sequence, a method of making a dna construct and the use thereof
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6395549B1 (en) 1998-10-22 2002-05-28 Medical College Of Georgia Research Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
AU784506B2 (en) * 1999-08-25 2006-04-13 Immunex Corporation Compositions and methods for improved cell culture
US6586205B1 (en) 2000-02-11 2003-07-01 Millennium Pharmaceuticals, Inc. 43239 a novel GPCR-like molecule and uses thereof
EP1263950A2 (en) 2000-02-11 2002-12-11 Millennium Pharmaceuticals, Inc. Seven-transmembrane proteins/g-protein coupled receptors
EP1430124B1 (en) 2000-09-20 2013-11-06 EMD Millipore Corporation Artificial ubiquitous chromatin opening elements (ucoe)
BRPI0210771B8 (pt) 2001-07-04 2021-05-25 Chromagenics Bv construção de dna recombinante, método para a produção de um produto de gene em uma célula, e, uso de uma sequência de dna
EP1273666A1 (en) 2001-07-04 2003-01-08 Chromagenics B.V. Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
DK1513937T3 (da) * 2002-06-14 2011-05-16 Chromagenics Bv Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved
WO2003106674A2 (en) 2002-06-14 2003-12-24 Chromagenics B.V. Means and methods for regulating gene expression
DK1573058T3 (da) 2002-12-18 2012-01-16 Chromagenics Bv Fremgangsmåde til forbedring af proteinproduktion
AU2003290453A1 (en) 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors

Also Published As

Publication number Publication date
EP1845162A1 (en) 2007-10-17
EP1404872A2 (en) 2004-04-07
DK1404872T3 (da) 2007-02-19
EP1829972A3 (en) 2007-10-24
IL193373A (en) 2010-12-30
EP1842919B1 (en) 2010-05-05
US20070031933A1 (en) 2007-02-08
US7736870B2 (en) 2010-06-15
DE60219221T2 (de) 2008-01-03
KR20090037960A (ko) 2009-04-16
EP1806407B1 (en) 2010-05-05
KR100942116B1 (ko) 2010-02-12
US7749733B2 (en) 2010-07-06
ES2344072T3 (es) 2010-08-17
BRPI0210771B8 (pt) 2021-05-25
IL193374A (en) 2010-12-30
EP1806407A2 (en) 2007-07-11
JP2010131024A (ja) 2010-06-17
JP2010131025A (ja) 2010-06-17
US20070031935A1 (en) 2007-02-08
EP1806407A3 (en) 2008-06-04
DK1808488T3 (da) 2010-10-18
AU2011202193A1 (en) 2011-06-02
EP1808488A3 (en) 2007-11-14
AU2007234619B2 (en) 2011-06-02
AU2007234619A1 (en) 2007-12-13
EP1829971A1 (en) 2007-09-05
CN1266282C (zh) 2006-07-26
ES2344071T3 (es) 2010-08-17
DK1842919T3 (da) 2010-08-16
EP1845162B1 (en) 2010-05-05
DK1600510T3 (da) 2007-06-25
ES2344073T3 (es) 2010-08-17
DE60236332D1 (de) 2010-06-17
US7736869B2 (en) 2010-06-15
ZA200309599B (en) 2006-05-31
ES2348174T3 (es) 2010-11-30
SG143066A1 (en) 2008-06-27
EP1829971A3 (en) 2008-06-04
ATE358183T1 (de) 2007-04-15
US20070026499A1 (en) 2007-02-01
EP1829972A2 (en) 2007-09-05
DE60219221D1 (de) 2007-05-10
US20030199468A1 (en) 2003-10-23
EP1829971B1 (en) 2010-05-05
AU2011202193B2 (en) 2011-09-29
ATE466944T1 (de) 2010-05-15
NO338477B1 (no) 2016-08-22
US20070026498A1 (en) 2007-02-01
CA2812799C (en) 2016-01-26
US20070037256A1 (en) 2007-02-15
ATE467682T1 (de) 2010-05-15
ES2344074T3 (es) 2010-08-17
PT1600510E (pt) 2007-06-25
US7662591B2 (en) 2010-02-16
MXPA03011801A (es) 2005-03-07
ATE343004T1 (de) 2006-11-15
NZ530218A (en) 2005-09-30
CN1524128A (zh) 2004-08-25
EP1600510A3 (en) 2006-02-22
DE60236379D1 (de) 2010-06-24
ATE466941T1 (de) 2010-05-15
US20070031936A1 (en) 2007-02-08
US7192741B2 (en) 2007-03-20
US7951586B2 (en) 2011-05-31
CA2450020A1 (en) 2003-01-16
BRPI0210771B1 (pt) 2015-12-22
US20070128717A1 (en) 2007-06-07
US7659094B2 (en) 2010-02-09
ATE466942T1 (de) 2010-05-15
BR0210771A (pt) 2004-07-13
ES2285630T3 (es) 2007-11-16
JP5014443B2 (ja) 2012-08-29
DE60237048D1 (de) 2010-08-26
EP1600510A2 (en) 2005-11-30
EP1842919A1 (en) 2007-10-10
US7736868B2 (en) 2010-06-15
EP1829972B1 (en) 2010-05-12
US20070031934A1 (en) 2007-02-08
ATE474053T1 (de) 2010-07-15
ES2274045T3 (es) 2007-05-16
EP1808488B1 (en) 2010-07-14
AU2002314629B2 (en) 2007-08-30
IL159674A (en) 2009-02-11
HK1068652A1 (en) 2005-04-29
DE60215502D1 (de) 2006-11-30
CY1107678T1 (el) 2013-04-18
DE60236334D1 (de) 2010-06-17
IL159674A0 (en) 2004-06-20
WO2003004704A2 (en) 2003-01-16
CA2812799A1 (en) 2003-01-16
DE60236331D1 (de) 2010-06-17
JP2004533262A (ja) 2004-11-04
DK1806407T3 (da) 2010-08-16
EP1404872B1 (en) 2006-10-18
WO2003004704A3 (en) 2003-10-16
JP4500044B2 (ja) 2010-07-14
KR100942117B1 (ko) 2010-02-12
DE60215502T2 (de) 2007-08-30
DE60236333D1 (de) 2010-06-17
DK1845162T3 (da) 2010-08-16
NO20040011L (no) 2004-03-03
ES2344070T3 (es) 2010-08-17
EP1600510B1 (en) 2007-03-28
EP1808488A2 (en) 2007-07-18
KR20090037485A (ko) 2009-04-15
US7655441B2 (en) 2010-02-02
CA2450020C (en) 2013-08-13
DK1829971T3 (da) 2010-08-16
JP5014444B2 (ja) 2012-08-29
ATE466943T1 (de) 2010-05-15

Similar Documents

Publication Publication Date Title
DK1806407T3 (da) DNA-sekvenser med anti-repressoraktivitet
BR0113109A (pt) Anticorpos antil-il-12, composições, métodos e usos
ATE542801T1 (de) Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
ATE328093T1 (de) Expression von phytase in pflanzen
DE69636511D1 (de) Amplifikation von einfachen sequenz wiederholungen
DE60036645D1 (de) Methoden zur identifizierung evolutionär signifikanter änderungen in polynukleotid- und polypeptidsequenzen in domestizierten pflanzen und tieren
ATE397753T1 (de) Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung
DE60027419D1 (de) Regulatorische Sequenzen des humanen MCP-1 Gens
Jozsef Poisonings of animal origin Review article. 3. Poisonings by Arthropoda. 2. Arachnida
DE602004019696D1 (de) Die multiple resistenz von pflanzen gegen phytopathogene und schädlinge induzierende proteine
DE50203158D1 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose
ITGE20040063A1 (it) Metodo per incrementare l'efficacia biologica dei campi elettromagnetici usati per il trattamento di esseri umani animali o piante.